eHealth for Screening Health Risks in Home-Based Older Adults: A Prospective Study
Launched by PRESAGE · Aug 24, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new tool called the PRESAGE CARE questionnaire, which uses technology to help identify health risks in older adults, particularly those who may be experiencing frailty or other age-related health issues. The goal is to see how well this questionnaire can detect problems like depression, undernutrition, cognitive impairment, and difficulties with daily activities. Researchers will be working with seniors at the Charles-Foix Hospital in France from October 2023 to July 2024, asking their family caregivers to complete the questionnaire on a digital app during hospital visits.
To participate in this study, caregivers must be family members of individuals aged 65 and older who are receiving care at the hospital and can provide consent to join the trial. Participants can expect to fill out the questionnaire, which will then help identify specific health risks for their loved ones. The researchers will also compare the results from this questionnaire with traditional health assessments conducted on the same day. This study is important because it aims to improve early detection of health issues in older adults using innovative technology, potentially leading to better care and support for them.
Gender
ALL
Eligibility criteria
- * Inclusion criteria :
- • 1. family members of individuals aged 65 and above,
- • 2. who are present within the day hospitalization service of Charles-Foix Hospital
- • 3. and able to provide informed consent.
- • Non inclusion criteria
- • 1. refuse to give their consent to participate in the study,
- • 2. or have cognitive impairments
- • 3. or are occasional caregivers.
About Presage
Presage is a leading clinical trial sponsor focused on advancing precision medicine through innovative biomarker-driven approaches. With a commitment to enhancing patient outcomes, Presage specializes in the development and commercialization of diagnostics and therapeutics that enable personalized treatment strategies. The company collaborates with healthcare professionals and research institutions to translate scientific discoveries into clinical applications, thereby fostering a deeper understanding of disease mechanisms and therapeutic responses. By prioritizing rigorous research and ethical standards, Presage aims to contribute significantly to the future of targeted therapies and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported